Catalyst Biosciences (NASDAQ:CBIO) reported quarterly earnings of $1.64 per share. This is a 356.25 percent increase over losses of $(0.64) per share from the same period last year.
REV Group Gears Up For Q3 Print; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts
REV Group, Inc. (NYSE: REVG) is expected to report its third quarter fiscal 2023 results financial results, before the opening bell on Sept. 13, 2023.
